MedTrace Logo

Perioperative Dexamethasone on Postoperative Outcome in IBD

NCT03456752 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2021-02-11

No results posted yet for this study

Summary

The objective of this RCT is to determine the efficacy of a single preoperative dose of Dexamethasone for accelerating the recovery and reducing the incidence of postoperative complications in adult patients undergoing intestinal resection for inflammatory bowel disease.

Conditions

  • Inflammatory Bowel Diseases
  • Dexamethasone
  • Postoperative Ileus
  • Postoperative Complications

Interventions

DRUG

Dexamethasone

Dexamethasone 8mg intravenously prior to induction of anesthesia

DRUG

Normal saline

Normal saline 1.6ml intravenously prior to induction of anesthesia

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Jianfeng Gong, MD · Jinling Hospital, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-12-13
Completion
2020-01-13

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456752 on ClinicalTrials.gov